JPRN-UMIN000012635
Recruiting
未知
Exploratory study evaluating efficacy, safety and mechanism of Daikenchuto on abdominal pain or bloating accompanied by Crohn disease. - CD DKT trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Subjects with quiescent Crohn disease having abdominal pain or bloating
- Sponsor
- Kurume university
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 Patients with short bowel syndrome 2 Patients who require surgical treatment 3 Patients with malignancy 4 Patients who can take medicines orally 5 Patients under treatment for psychiatric disorder (including depression) 6 Patients with stoma 7 Patients who took Kampo medicines within 4weeks before enrollment 8 Patients taking drugs under development 9 Patients with serious complications (liver, kidney, heart, circulatory, or metabolic disorder) 10 Patients who are lactating, pregnant or considering conception 11 Others, including patients who are unfit for the study as determined by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Photodynamic diagnosis by LED endoscopy systemAlimentary canal tumorJPRN-jRCTs061200034Isomoto Hajime60
Recruiting
Not Applicable
Exploratory study evaluating efficacy and safety of daikenchuto for the treatment of the postoperative abdominal pain or bloating in patients undergoing hepatectomy.Abdominal pain or bloating after hepatectomyJPRN-UMIN000028950agasaki University40
Completed
Not Applicable
Exploratory study evaluating efficacy and safety of hangeshashinto for treatment of Everolimus-associated stomatitis in patients with breast cancer.JPRN-UMIN000031196Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital60
Recruiting
Not Applicable
Exploratory study of hochuekkito for exercise capacity of patients with heart failure (HET Study)Heart failure patients scheduled to undergo home-based cardiac rehabilitationheart failureJPRN-jRCTs031230348Amiya Eisuke30
Completed
Phase 1
A clinical study to evaluate efficacy, safety and tolerability of ISN001 in dystrophic epidermolysis bullosa patients.dystrophic epidermolysis bullosaJPRN-UMIN000028366Ishin Pharmaceutical Co. Ltd.5